|
|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 13:00 14-May-2013 | GWP | Notice of Results | RNS | +1.17%  |
| 16:28 10-May-2013 | GWP | Holding(s) in Company | RNS | +0.17% |
| 16:24 10-May-2013 | GWP | Holding(s) in Company | RNS | +0.17% |
| 15:40 09-May-2013 | GWP | Total Voting Rights | RNS | -1.05%  |
| 08:00 08-May-2013 | GWP | Closing of Initial Public Offering on Nasdaq | RNS | -1.79% |
| 07:00 07-May-2013 | GWP | Sativex Commercialization Approval in Italy | RNS | -7.98% |
| 17:47 01-May-2013 | GWP | Pricing of U.S. Initial Public Offering | RNS | -18.25% |
| 07:00 22-Apr-2013 | GWP | US Patent Allowance for SATIVEX Formulation Spray | RNS | +2.80% |
| 14:23 18-Apr-2013 | GWP | Amendment to Registration Statement for NASDAQ | RNS | -2.73% |
| 10:31 12-Apr-2013 | GWP | Results of General Meeting | RNS | -9.10% |
| 07:00 10-Apr-2013 | GWP | Sativex moved to Schedule 4 of UK Drugs Act | RNS | +1.95% |
| 07:00 03-Apr-2013 | GWP | New US Patent Allowance for Delivery of SATIVEX | RNS | +38.80% |
| 14:35 22-Mar-2013 | GWP | Posting of Shareholder Circular | RNS | -17.29% |
| 14:46 19-Mar-2013 | GWP | Appoints Stephen Schultz VP of Investor Relations | RNS | -8.08% |
| 13:10 19-Mar-2013 | GWP | Update on Sativex in Germany | RNS | -8.08% |
| 13:01 19-Mar-2013 | GWP | Filing for listing on NASDAQ | RNS | -8.08% |
| 15:16 19-Feb-2013 | GWP | Directorate Change | RNS | +0.18% |
| 09:30 19-Feb-2013 | GWP | Blocklisting Interim Review | RNS | +0.18% |
| 11:44 21-Jan-2013 | GWP | Result of AGM | RNS | -3.04% |
| 10:04 04-Dec-2012 | GWP | Director/PDMR Shareholding | RNS | -4.26% |
GW PHARM. - News Analysis
Company overview
Group site
Investor relations
Press office
Careers
Events & Studios
Academy Training
Business days
Regulatory policy
© 2013 London Stock Exchange plc. All rights reserved